Hold Parameters on Likely Cardiovascular Depressant Medications

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2006-08-31

Study Completion Date

2006-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This pilot study is being pursued to observe whether certain medications are given to patients within a timeframe where their being given could play a part in a critical event in the management of the patient.

There are general rules about when it would be appropriate for these types of medications not to be given. However, it is not current standard practice for the criteria to be put in place without the expressed wishes of the ordering physician or their agent.

Research Question:

Can the administration of cardio-depressant medications be documented as a significant risk factor for hypotensive or bradycardic events?

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Autonomic Determinants of POTS - Pilot 2

NCT04140721

Postural Tachycardia Syndrome

ACTIVE_NOT_RECRUITING EARLY_PHASE1

Autonomic Determinants of POTS - Pilot1

NCT04050410

Postural Tachycardia Syndrome

ACTIVE_NOT_RECRUITING EARLY_PHASE1

Hemodynamic Response of Neuropathic And Non-Neuropathic POTS Patients To Adrenoreceptor Agonist And Antagonist

NCT03070730

Postural Orthostatic Tachycardia Syndrome Orthostatic Intolerance

TERMINATED PHASE1/PHASE2

Using Mirabegron to Increase BP in Patients With POTS

NCT06133075

Postural Orthostatic Tachycardia Syndrome Chronic Orthostatic Intolerance Syncope

COMPLETED PHASE2

Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure

NCT02897063

Autonomic Failure Pure Autonomic Failure Multiple System Atrophy +2 more

RECRUITING PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asystole Bradycardia Hypotension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Serial evaluation of the first 50 documented events of Code Blue or call to Rapid Response Team involving hypotension, bradycardia or asystole in the adult inpatient population events beginning January 1, 2006.

Eligible Sex

ALL

Accepts Healthy Volunteers

No